An essential role of PDCD4 in vascular smooth muscle cell apoptosis and proliferation: Implications for vascular disease

American Journal of Physiology - Cell Physiology

Volumn 298, Issue 6, 2010, Pages

  Liu, Xiaojun ^a   Cheng, Yunhui ^a   Yang, Jian ^a   Krall, Thomas J ^a   Huo, Yuqing ^b   Zhang, Chunxiang ^a,c  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

Activator protein 1; Programmed cell death 4

Indexed keywords

ADENOVIRUS VECTOR; PLATELET DERIVED GROWTH FACTOR; PROGRAMMED CELL DEATH 4; PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERY INJURY; ARTICLE; BALLOON; BLOOD VESSEL WALL; CAROTID ARTERY; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; GENE OVEREXPRESSION; IN VITRO GENE TRANSFER; IN VIVO STUDY; KNOCKOUT GENE; MALE; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BALLOON DILATATION; CAROTID ARTERY INJURIES; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; TRANSFECTION;

ADENOVIRIDAE; RATTUS;

EID: 77952612620     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00413.2009     Document Type: Article

References (24)

1. Cheng Y, Liu X, Yang J, Lin Y, Xu D, Lu Q, Deitch EA, Huo Y, Delphin E, Zhang C. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 105: 158-166, 2009.
2. 2-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol 47: 5-14, 2009.
3. Clarke M, Bennett M. The emerging role of vascular smooth muscle cell apoptosis in atherosclerosis and plaque stability. Am J Nephrol 26: 531-535, 2006. (Pubitemid 46143874)
4. Göke R, Gregel C, Göke A, Arnold R, Schmidt H, Lankat-Buttgereit B. Programmed cell death protein 4 (PDCD4) acts as a tumor suppressor in neuroendocrine tumor cells. Ann NY Acad Sci 1014: 220-221, 2004. (Pubitemid 38594809)
5. Herrmann J, Ciechanover A, Lerman LO, Lerman A. The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended. Cardiovasc Res 61: 11-21, 2004. (Pubitemid 38056676)
6. Hwang SK, Jin H, Kwon JT, Chang SH, Kim TH, Cho CS, Lee KH, Young MR, Colburn NH, Beck GR Jr, Yang HS, Cho MH. Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. Gene Ther 14: 1353-1361, 2007. (Pubitemid 47365621)
7. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ Res 100: 1579-1588, 2007. (Pubitemid 46897261)
8. Karin M, Shaulian E. AP-1: linking hydrogen peroxide and oxidative stress to the control of cell proliferation and death. IUBMB Life 52: 17-24, 2001. (Pubitemid 33769664)
9. Kockx MM, Herman AG. Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res 45: 736-746, 2000.
10. Korshunov VA, Berk BC. Smooth muscle apoptosis and vascular remodeling. Curr Opin Hematol 15: 250-254, 2008. (Pubitemid 351507578)
11. Lankat-Buttgereit B, Göke R. Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy? Biol Cell 95: 515-519, 2003. (Pubitemid 37461481)
12. Lankat-Buttgereit B, Göke R. The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell 101: 309-517, 2009.
13. Lankat-Buttgereit B, Lenschen B, Schmidt H, Göke R. The action of Pdcd4 may be cell type specific: evidence that reduction of dUTPase levels might contribute to its tumor suppressor activity in Bon-1 cells. Apoptosis 13: 157-164, 2008.
14. Li H, Telemaque S, Miller RE, Marsh JD. High glucose inhibits apoptosis induced by serum deprivation in vascular smooth muscle cells via upregulation of Bcl-2 and Bcl-xl. Diabetes 54: 540-545, 2005.
15. Lin Y, Liu X, Cheng Y, Yang J, Huo Y, Zhang C. Involvement of microRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. J Biol Chem 284: 7903-7913, 2009.
16. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C. A necessary role of miR-222 and miR-221 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104: 476-487, 2009.
17. Mayr M, Xu Q. Smooth muscle cell apoptosis in arteriosclerosis. Exp Gerontol 36: 969-987, 2001. (Pubitemid 32515215)
18. Orford JL, Selwyn AP, Ganz P, Popma JJ, Rogers C. The comparative pathobiology of atherosclerosis and restenosis. Am J Cardiol 86: 6H-11H, 2000.
19. Schwartz SM, Reidy MA, O'Brien ER. Assessment of factors important in atherosclerotic occlusion and restenosis. Thromb Haemost 74: 541-551, 1995.
20. Schwartz SM. How vessels narrow. Z Kardiol 84: S129-S135, 1995.
21. Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400, 2001.
22. Shibahara K, Asano M, Ishida Y, Aoki T, Koike T, Honjo T. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 1166: 297-301, 1995. (Pubitemid 26007637)
23. Yang HS, Knies JL, Stark C, Colburn NH. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene 22: 3712-3720, 2003. (Pubitemid 36760733)
24. Zhang Z, DuBois RN. Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor. Oncogene 20: 4450-4456, 2001. (Pubitemid 32772427)